[ Price : $8.95]
PhRMAs general counsel says FDA and industry need to revisit how the biopharmaceutical industry communicates with healthcare profe...[ Price : $8.95]
Federal Register Notice: FDA and the Centers for Medicare and Medicaid Services will extend a pilot program for an additional two ...[ Price : $8.95]
FDA grants orphan drug designation to Versartis for its long-acting form of recombinant human growth hormone.[ Price : $8.95]
Mylan signs an agreement with Pfizer for worldwide rights to develop a novel long-acting muscarinic antagonist compound for variou...[ Price : $8.95]
Scientists from two U.S. government national laboratories recommend using certain X-rays to speed investigations aimed at understa...[ Price : $8.95]
FDA says it is working with the European Medicines Agency and five European countries on joint inspections of bioequivalence studi...[ Price : $8.95]
An updated CDER internal policy outlines procedures for identifying review issues during the filing review of all original NDAs, B...[ Price : $8.95]
FDA plans to update its administrative regulations in 21 CFR Part 10 to include an electronic method for citizen petition submissi...